Toxic multinodular goiter: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Toxic multinodular goiter}} | {{Toxic multinodular goiter}} | ||
{{CMG}}; {{AE}} {{Ajay}} {{ARK}} {{Akshun}} {{Mazia}} {{SKA}} | {{CMG}}; {{AE}} {{Ajay}} {{ARK}} {{Akshun}} {{Mazia}} {{SKA}} | ||
Revision as of 21:20, 9 October 2017
|
Toxic multinodular goiter Microchapters |
|
Differentiating Toxic multinodular goiter from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Toxic multinodular goiter On the Web |
|
American Roentgen Ray Society Images of Toxic multinodular goiter |
|
Risk calculators and risk factors for Toxic multinodular goiter |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ajay Gade MD[2]] Aravind Reddy Kothagadi M.B.B.S[3] Akshun Kalia M.B.B.S.[4] Mazia Fatima, MBBS [5] Sunny Kumar MD [6]
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Toxic multinodular goiter from other Diseases
Epidemiology and Demographics
Risk Factors
Common risk factors in the development of multinodular goiter include female sex,age over 50 years,areas with decreased iodine intake,iodine supplementation, natural goitrogens,vitamin A and iron deficiency,selenium deficiency.
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X-Ray Findings | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings
Treatment
Medical Therapy | Surgery | | Radiation Therapy |Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies